BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15211118)

  • 1. A comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis.
    Sáez J; Martínez J; Trigo C; Sánchez-Payá J; Griñó P; Compañy L; Laveda R; Penalva JC; García C; Pérez-Mateo M
    Pancreas; 2004 Jul; 29(1):e9-14. PubMed ID: 15211118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis.
    Sáez J; Martínez J; Trigo C; Sánchez-Payá J; Compañy L; Laveda R; Griñó P; García C; Pérez-Mateo M
    World J Gastroenterol; 2005 Dec; 11(46):7261-5. PubMed ID: 16437625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis.
    Appelros S; Petersson U; Toh S; Johnson C; Borgström A
    Br J Surg; 2001 Feb; 88(2):216-21. PubMed ID: 11167870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte chemoattractant protein 1, active carboxypeptidase B and CAPAP at hospital admission are predictive markers for severe acute pancreatitis.
    Regnér S; Appelros S; Hjalmarsson C; Manjer J; Sadic J; Borgstrom A
    Pancreatology; 2008; 8(1):42-9. PubMed ID: 18235216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
    Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study.
    Neoptolemos JP; Kemppainen EA; Mayer JM; Fitzpatrick JM; Raraty MG; Slavin J; Beger HG; Hietaranta AJ; Puolakkainen PA
    Lancet; 2000 Jun; 355(9219):1955-60. PubMed ID: 10859041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis.
    Lempinen M; Stenman UH; Finne P; Puolakkainen P; Haapiainen R; Kemppainen E
    J Surg Res; 2003 May; 111(2):267-73. PubMed ID: 12850473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.
    Khan Z; Vlodov J; Horovitz J; Jose RM; Iswara K; Smotkin J; Brown A; Tenner S
    Am J Gastroenterol; 2002 Aug; 97(8):1973-7. PubMed ID: 12190163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.
    Tenner S; Fernandez-del Castillo C; Warshaw A; Steinberg W; Hermon-Taylor J; Valenzuela JE; Hariri M; Hughes M; Banks PA
    Int J Pancreatol; 1997 Apr; 21(2):105-10. PubMed ID: 9209951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis.
    Huang QL; Qian ZX; Li H
    Hepatogastroenterology; 2010; 57(102-103):1295-9. PubMed ID: 21410075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis.
    Appelros S; Thim L; Borgström A
    Gut; 1998 Jan; 42(1):97-102. PubMed ID: 9505893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the activation peptide released from procarboxypeptidase B (CAPAP) and anionic trypsinogen in patients with acute abdominal disorders of non-pancreatic origin.
    Müller CA; Appelros S; Uhl W; Büchler MW; Borgström A
    Pancreatology; 2003; 3(2):149-55. PubMed ID: 12748424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the severity of acute pancreatitis on admission by carboxypeptidase-B activation peptide: A systematic review and meta-analysis.
    Deng L; Wang L; Yong F; Xiong J; Jin T; De La Iglesia-Garcia D; Bharucha S; Altaf K; Huang W; Xia Q
    Clin Biochem; 2015 Jul; 48(10-11):740-6. PubMed ID: 25920892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan.
    Yasuda H; Kataoka K; Takeyama Y; Takeda K; Ito T; Mayumi T; Isaji S; Mine T; Kitagawa M; Kiriyama S; Sakagami J; Masamune A; Inui K; Hirano K; Akashi R; Yokoe M; Sogame Y; Okazaki K; Morioka C; Kihara Y; Kawa S; Tanaka M; Andoh A; Kimura W; Nishimori I; Furuse J; Yokota I; Shimosegawa T
    World J Gastroenterol; 2019 Jan; 25(1):107-117. PubMed ID: 30643362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential changes in pancreatic markers in acute pancreatitis.
    Lempinen M; Stenman UH; Puolakkainen P; Hietaranta A; Haapiainen R; Kemppainen E
    Scand J Gastroenterol; 2003 Jun; 38(6):666-75. PubMed ID: 12825877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis.
    Gudgeon AM; Heath DI; Hurley P; Jehanli A; Patel G; Wilson C; Shenkin A; Austen BM; Imrie CW; Hermon-Taylor J
    Lancet; 1990 Jan; 335(8680):4-8. PubMed ID: 1967341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAPAP in acute pancreatitis: just another marker or real progress?
    Büchler MW; Uhl W; Andrén-Sandberg A
    Gut; 1998 Jan; 42(1):8-9. PubMed ID: 9505874
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis.
    Abu Hilal M; Ung CT; Westlake S; Johnson CD
    J Gastroenterol Hepatol; 2007 Mar; 22(3):349-54. PubMed ID: 17295766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease activation, pancreatic leakage, and inflammation in acute pancreatitis: differences between mild and severe cases and changes over the first three days.
    Regnér S; Manjer J; Appelros S; Hjalmarsson C; Sadic J; Borgström A
    Pancreatology; 2008; 8(6):600-7. PubMed ID: 18849642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
    Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
    Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.